[Analysis on animal models of experimental hyperlipidemia]

Area of Science:

• Biomedical Research
• Pharmacology
• Animal Modeling

Background:

• Hyperlipidemia is a significant risk factor for serious health conditions like fatty liver and atherosclerosis.
• The incidence of hyperlipidemia is increasing and affecting younger populations, highlighting the need for effective treatments.
• Developing new lipid-lowering drugs is a key research area, with animal models essential for evaluating traditional Chinese medicine.

Purpose of the Study:

• To review and summarize recent advancements in the methods used to create animal models of experimental hyperlipidemia.
• To provide a comprehensive reference for researchers in selecting appropriate and effective hyperlipidemia animal models.
• To ensure the reliability and accuracy of experimental hyperlipidemia research.

Main Methods:

• Literature review of recent research on hyperlipidemia animal model replication.
• Analysis of various methods for inducing and validating hyperlipidemia in animal subjects.
• Evaluation of model characteristics including similarity to human disease, repeatability, simplicity, and generalizability.

Main Results:

• Successful replication of hyperlipidemia animal models is critical for experimental validity.
• An ideal model should closely mimic human hyperlipidemia, be highly repeatable, simple to create, and broadly applicable.
• Various methods exist for creating hyperlipidemia models, each with its own advantages and limitations.

Conclusions:

• The choice of method for replicating hyperlipidemia animal models significantly impacts research reliability.
• This review offers a foundation for hypolipidemic drug developers to rationally select effective animal modeling techniques.
• Further research into optimizing animal models is essential for advancing hyperlipidemia treatment strategies.